Is topical treatment effective for psoriasis in patients who failed topical treatment?

被引:6
作者
Okwundu, Nwanneka [1 ]
Cardwell, Leah [1 ]
Cline, Abigail [1 ]
Richardson, Irma [1 ]
Feldman, Steven R. [1 ,2 ,3 ]
机构
[1] Wake Forest Sch Med, Ctr Dermatol Res, Dept Dermatol, Winston Salem, NC 27157 USA
[2] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC 27157 USA
[3] Wake Forest Sch Med, Dept Social Sci & Hlth Policy, Winston Salem, NC 27157 USA
关键词
Desoximetasone; adherence; corticosteroid; treatment; tachyphylaxis; ADHERENCE; CORTICOSTEROIDS; SPRAY; NONADHERENCE; 0.05-PERCENT;
D O I
10.1080/09546634.2019.1617830
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objectives: To determine if resistance to topical treatments can be overcome under conditions promoting adherence. Materials and Methods: Twelve psoriasis patients treated with topical 0.25% desoximetasone spray were randomized to either twice daily phone call reminders or no phone call and were treated for 2 weeks. Pruritus Visual Analog Scale (VAS), Psoriasis Area and Severity Index (PASI), Total Lesion Severity Score (TLSS), and, Investigator Global Assessment (IGA) assessed disease severity. Results: Most subjects improved in most scoring parameters. 100%, 91.7%, 83.3%, and 58.3% had improvements in itching, PASI, TLSS, and IGA, respectively. Conclusions: While our sample size was small and treatment duration short, the effect size of topical treatment was large under conditions designed to promote adherence.
引用
收藏
页码:41 / 44
页数:4
相关论文
共 15 条
  • [1] Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring
    Alinia, H.
    Tuchayi, S. Moradi
    Smith, J. A.
    Richardson, I. M.
    Bahrami, N.
    Jaros, S. C.
    Sandoval, L. F.
    Farhangian, M. E.
    Anderson, K. L.
    Huang, K. E.
    Feldman, S. R.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (03) : 759 - 764
  • [2] Beutner Karl, 2006, J Drugs Dermatol, V5, P357
  • [3] Assessing adherence to inhaled corticosteroids in asthma patients using an integrated measure based on primary and secondary adherence
    Blais, Lucie
    Kettani, Fatima-Zohra
    Forget, Amelie
    Beauchesne, Marie-France
    Lemiere, Catherine
    Ducharme, Francine M.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (01) : 91 - 97
  • [4] Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: Commonly used methods of measuring adherence to topical therapy overestimate actual use
    Carroll, CL
    Feldman, SR
    Camacho, FT
    Manuel, JC
    Balkrishnan, R
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (02) : 212 - 216
  • [5] Chiricozzi A, 2017, DERMATOL THER, V30, P1
  • [6] New topical treatments change the pattern of treatment of psoriasis: dermatologists remain the primary providers of this care
    Feldman, SR
    Fleischer, AB
    Cooper, JZ
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2000, 39 (01) : 41 - 44
  • [7] Keegan BR, 2015, J DRUGS DERMATOL, V14, P835
  • [8] Topical corticosteroids in dermatology
    Mehta, Aayushi B.
    Nadkarni, Nitin J.
    Patil, Sharmila P.
    Godse, Kiran V.
    Gautam, Manjyot
    Agarwal, Shweta
    [J]. INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2016, 82 (04) : 371 - 378
  • [9] Menter A, 2007, CUTIS, V80, P12
  • [10] Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement
    Mooney, Emma
    Rademaker, Marius
    Dailey, Rebecca
    Daniel, Ben S.
    Drummond, Catherine
    Fischer, Gayle
    Foster, Rachael
    Grills, Claire
    Halbert, Anne
    Hill, Sarah
    King, Emma
    Leins, Elizabeth
    Morgan, Vanessa
    Phillips, Roderic J.
    Relic, John
    Rodrigues, Michelle
    Scardamaglia, Laura
    Smith, Saxon
    Su, John
    Wargon, Orli
    Orchard, David
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2015, 56 (04) : 241 - 251